$32.01
−1.39%Price chart
Oct 7Oct 12Oct 15Oct 20Oct 23Oct 28Nov 2Nov 5
Key dataNov 5, 2026
Open$32.55
From 52W high−13.25%
Volume2.82M
Market cap$13.40B
P/E (TTM)21.3x
P/S (TTM)2.1x
Div yield2.43%
Key dataNov 5, 2026
Open
$32.55
From 52W high
−13.25%
Volume
2.82M
Market cap
$13.40B
ValuationView details →
P/E (Fwd)
14.3x
EV/EBITDA
11.0x
P/E (TTM)
21.3x
RSI (14)
69.2
MomentumView details →
1D Return
−1.39%
YTD Return
−2.53%
SummaryUpdated Jun 1, 2026
Smith & Nephew plc (NYSE:SNN) is a British multinational medical technology company founded in 1856 and headquartered in Watford, United Kingdom. Originally established as a pharmacy business by Thomas James Smith, the company has evolved over more than 165 years into one of the world's leading medical device manufacturers. Smith & Nephew went public on the New York Stock Exchange in 1999 and today operates globally, serving healthcare providers across established and emerging markets. The company has undergone significant strategic transformation in recent years, implementing a comprehensive 12-point improvement plan to enhance operational efficiency and drive consistent growth across its medical device portfolio.
Similar companies
Latest newsMore news →
SMITH & NEPHEW PLC was in talks to combine with JOHNSON & JOHNSON’s orthopaedics unit, but the talks fell apart after SMITH & NEPHEW PLC refused to agree to the unit’s former CEO leading the combined business.14d agoThe UK and India’s CETA Marketplace is scheduled to take place in Mumbai on October 13, bringing together UK ministers, seven Northern England mayors and more than 100 British businesses to explore trade and investment opportunities.26d ago